研究者
J-GLOBAL ID：201301001096415890
更新日: 2024年02月14日
池田 悠至
イケダ ユウジ | Ikeda Yuji
所属機関・部署：
職名：
准教授
論文 (3件)：
-
A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2). Vaccines (Basel). 2021
-
High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo. J Gynecol Oncol. 2020. e93
-
Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate (MPA) in patients with grade 1 endometrioid adenocarcinoma. Mol Clin Oncol. 2016. 4. 4. 492-496
MISC (33件)：
-
Matsuda T, Leisegang M, Park JH et al. Induction of Neoantigen-specific Cytotoxic T Cells and Construction of T-cell Receptor-engineered T cells for Ovarian Cancer. Clin Cancer Res. 2018. 24. 21. 5357-5367
-
Matsuo K, Takazawa Y, Ross MS et al. Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma. Ann Surg Oncol. 2018. 25. 12. 3676-3684
-
Matsuo K, Ross MS, Yunokawa M et al. Clinical utility of CA-125 in the management of uterine carcinosarcoma. J Gynecol Oncol. 2018. 29. 6. e88
-
Chuwa AH, Sone K, Oda K. Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer. Oncol Lett. 2018. 16. 5. 6195-6201
-
Matsuo K, Takazawa Y, Ross MS et al. Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma. Ann Surg Oncol. 2018. 25. 9. 2756-2766
もっと見る
経歴 (3件)：
- 2018/04 - 現在 日本大学医学部附属産婦人科学教室
- 2018/04/01 - 日本大学医学部附属産婦人科学教室
- 埼玉医科大学 医学部国際医療センター 産婦人科(婦人科腫瘍科) 助教
前のページに戻る
